An Unusual MHC Molecule Generates Protective CD8+ T Cell Responses to Chronic Infection

Alexandra Tsitsiklis,Derek J. Bangs,Lydia K. Lutes,Shiao W. Chan,Kristina M. Geiger,Andrew J. Modzelewski,Lara Labarta-Bajo,Yang Wang,Elina I. Zuniga,Shaodong Dai,Ellen A. Robey
DOI: https://doi.org/10.3389/fimmu.2020.01464
IF: 7.3
2020-07-08
Frontiers in Immunology
Abstract:The CD8+ T cell response to the intracellular parasite <i>Toxoplasma gondii</i> varies dramatically between mouse strains, resulting in stark differences in control of the parasite. Protection in BALB/c mice can be attributed to an unusually strong and protective MHC-1 L<sup>d</sup>-restricted CD8+ T cell response directed against a peptide derived from the parasite antigen GRA6. The MHC-1 L<sup>d</sup> molecule has limited peptide binding compared to conventional MHC molecules such as K<sup>b</sup> or D<sup>b</sup>, which correlates with polymorphisms associated with "elite control" of HIV in humans. To investigate the link between the unusual MHC-1 molecule L<sup>d</sup> and the generation of "elite controller" CD8+ T cell responses, we compared the GRA6-L<sup>d</sup> specific T cell response to the well-studied OVA-K<sup>b</sup> specific response, and demonstrated that GRA6-L<sup>d</sup> specific T cells are significantly more protective and resistant to exhaustion in chronic <i>T. gondii</i> infection. To further investigate the connection between limited peptide presentation and robust T cell responses, we used CRISPR/Cas9 to generate mice with a point mutation (W97R) in the peptide-binding groove of L<sup>d</sup> that results in broader peptide binding. We investigated the effect of this L<sup>d</sup> W97R mutation on another robust L<sup>d</sup>-restricted response against the IE1 peptide during Murine Cytomegalovirus (MCMV) infection. This mutation leads to an increase in exhaustion markers in the IE1-L<sup>d</sup> specific CD8+ T cell response. Our results indicate that limited peptide binding by MHC-1 L<sup>d</sup> correlates with the development of robust and protective CD8+ T cell responses that may avoid exhaustion during chronic infection.
immunology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore how specific major histocompatibility complex (MHC) molecules affect the response of CD8+ T cells in chronic infections. Specifically, the researchers focused on an unusual MHC - I molecule, Ld. This molecule has limited peptide - binding capacity but is able to generate a protective CD8+ T - cell response against chronic infections. By comparing T - cell responses restricted by different MHCs, the paper explored the relationship between limited peptide - binding capacity and the anti - fatigue characteristics of T cells, and how these characteristics contribute to maintaining an effective immune response in chronic infections. ### Research Background - **Individual Differences**: There are significant differences in CD8+ T - cell responses to intracellular infections (such as HIV) among different individuals. Some individuals can naturally control the virus, which is related to specific MHC - I alleles. - **Characteristics of MHC - I Molecules**: Different MHC - I molecules vary in peptide - binding capacity. Some MHC - I molecules (such as HLA - B57 and B27) are associated with "elite controllers", individuals who can effectively control HIV infection. - **Self - Reactivity of T Cells**: The self - reactivity of T cells also affects their ability to respond to foreign antigens. T cells with high self - reactivity usually show stronger reactivity. ### Research Objectives - **Explore the Specialties of Ld Molecules**: The researchers hope to reveal how Ld molecules generate "elite controller" CD8+ T - cell responses by comparing Ld - restricted T - cell responses with those restricted by other MHC - I molecules (such as Kb). - **T - cell Fatigue in Chronic Infections**: Explore whether limited peptide - binding capacity helps T cells avoid fatigue in chronic infections, thereby maintaining a long - term protective immune response. ### Experimental Design - **Compare T - cell Responses Restricted by Different MHCs**: The researchers used a transgenic mouse model to compare the protective ability and fatigue degree of GRA6 - Ld - specific and OVA - Kb - specific CD8+ T cells in toxoplasma gondii infection respectively. - **Point Mutation Experiment**: A point mutation (W97R) of the Ld molecule was generated by CRISPR - Cas9 technology. This mutation results in a wider peptide - binding range of the Ld molecule, and the impact of this change on T - cell responses was observed. ### Main Findings - **Ld - restricted T - cell Responses are More Effective**: Ld - restricted T cells show stronger protective ability and lower fatigue degree when fighting against toxoplasma gondii infection. - **Point Mutation Affects T - cell Responses**: The Ld W97R mutation leads to an increase in T - cell surface expression, but at the same time increases the expression of T - cell fatigue markers, indicating that the expansion of the peptide - binding range may be unfavorable to the persistence of T cells in chronic infections. ### Conclusion The research results show that MHC - I molecules with limited peptide - binding capacity (such as Ld) may help generate CD8+ T cells that can continuously function without being easily fatigued in chronic infections. This finding provides a new perspective for understanding how MHC - I molecules affect T - cell responses and is of great significance for the development of immunotherapies for chronic infections.